Hyaluronic acid nanoparticles encapsulated with miR-125b specifically target TAMs in the peritoneal cavity of ID8-VEGF ovarian cancer mice and repolarize macrophages to an immune-activating phenotype (54). Here, VEGFA is linked to ovarian cancer.